Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung Cancer
Clinical trial NCT01211483 · COMPLETED
Trial details
- NCT number
- NCT01211483
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2013-10-01
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.